Octapharma AG: Pharmaceuticals and Healthcare Company Profile & SWOT ReportiCD ResearchFebruary 4, 2012 22 Pages - SKU: ICDR6793089 |
| Synopsis ICD Research's Octapharma AG: Pharmaceuticals and Healthcare Company Profile & SWOT Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's Octapharma AG: Pharmaceuticals and Healthcare Company Profile & SWOT Report is a crucial resource for industry executives and anyone looking to access key information about Octapharma AG. ICD Research's Octapharma AG: Pharmaceuticals and Healthcare Company Profile & SWOT Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Octapharma AG (Octapharma) develops, produces and distributes finished plasma products around the world. The company is focused on the research and development of human proteins in the fields of haematology, immunotherapy, intensive care and emergency medicine. It offers a variety of plasma products for the treatment of coagulation disorders and immune diseases. In addition to plasma products, Octapharma offers plasma-based services such as supporting self-sufficiency partners and providing technology transfers through licensing. The company operates six production facilities located in Austria, France, Germany, Sweden and Mexico. In addition it operates 54 plasma donation centers and 62 plasma collection centers in the US and Europe. The company operates through 37 subsidiaries and representative offices in over 80 countries. Octapharma is headquartered in Lachen, Switzerland. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

